These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6394340)

  • 1. Analysis of in situ inflammation of allogeneic canine kidney grafts under antilymphocyte globulin treatment.
    Block T; Jarck HU; Hammer C; Bernheim C; Gokel M
    Eur Surg Res; 1984; 16(6):340-7. PubMed ID: 6394340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine-needle aspiration cytology of human renal transplants.
    von Willebrand E
    Clin Immunol Immunopathol; 1980 Nov; 17(3):309-22. PubMed ID: 7000402
    [No Abstract]   [Full Text] [Related]  

  • 3. Monitoring of human renal allograft rejection with fine-needle aspiration cytology.
    Häyry P; von Willebrand E
    Scand J Immunol; 1981; 13(1):87-97. PubMed ID: 7015482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active enhancement of dog kidney allografts using ALG and donor platelets.
    Rowiński W; Ryffa T; Stepkowski S; Woźniewicz B; Ruka M; Wasowska B; Hay M; Olszewski W
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1013-9. PubMed ID: 373670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolongation of pancreatic islet cell allograft survival by graft pretreatment with antilymphoblast globulin (ALG).
    Toledo-Pereyra LH; Gordon DA; MacKenzie GH
    Am Surg; 1982 Jun; 48(6):282-6. PubMed ID: 6805380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-induced donor-specific unresponsiveness to kidney allografts in mongrel dogs treated with ALG.
    Rowinski W; Ryffa T; Ruke M; Wasowska B; Tilney NL; Olszewski WL
    Transplant Proc; 1981 Mar; 13(1 Pt 1):586-8. PubMed ID: 6168052
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolonged survival of canine liver allografts perfused with antilymphocyte globulin (ALG).
    Toledo-Pereyra LH; Condie RM; Callender CO; Sharp H; Buselmeier TJ; Simmons RL; Najarian JS
    Trans Am Soc Artif Intern Organs; 1976; 22():211-5. PubMed ID: 781981
    [No Abstract]   [Full Text] [Related]  

  • 8. Transplant aspiration cytology for monitoring of kidney xenograft (wolf-dog) under cyclosporin A treatment.
    Danko I; Gebhard C; Scholz S; Gokel J; Hammer C
    Eur Surg Res; 1983; 15(5):276-83. PubMed ID: 6352275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The influence of pretreatment with specific antibodies on Renal Xenograft Rejection (author's transl)].
    Stemberger H; Rauhs R; Thetter O; Tamer A; Mayr WR; Kux M
    Wien Klin Wochenschr; 1978 Mar; 90(6):197-200. PubMed ID: 345629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antilymphocyte globulin and renal transplantation.
    Tagnon A
    Postgrad Med J; 1976; 52(5 Suppl):64-6. PubMed ID: 792848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized prospective clinical trial of antilymphocyte globulin in 100 cadaveric renal transplants.
    Sansom JR; Barnes AD; Hall CL
    Postgrad Med J; 1976; 52(5 Suppl):75-8. PubMed ID: 792851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation.
    Taylor HE; Ackman CF; Horowitz I
    Can Med Assoc J; 1976 Dec; 115(12):1205-8. PubMed ID: 793705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment with antilymphocyte globulin and donor cells on graft prolongation in an experimental model and some observations on graft-versus-host reaction.
    Pegrum GD; Williams G; Markwick J; Barnes RM
    Postgrad Med J; 1976; 52(5 Suppl):47-50. PubMed ID: 11454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antilymphocyte globulin pretreatment combined with azathioprine in the prolongation of dog renal allografts.
    Alexander JL; Macdonald AS; Kay RE; Busch GJ; Monteiro da Cunha JE; Birtch AG; Murray JE
    Surg Forum; 1968; 19():188-90. PubMed ID: 4180621
    [No Abstract]   [Full Text] [Related]  

  • 15. Antilymphocyte globulin (ALG) reverses "irreversible" allograft rejection.
    Light JA; Alijani MR; Biggers JA; Oddenino K; Reinmuth B
    Transplant Proc; 1981 Mar; 13(1 Pt 1):475-81. PubMed ID: 7022877
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved survival of heart transplants. Graft and/or donor pretreatment with antilymphoblast globulin, cyclophosphamide, or methylprednisolone.
    Toledo-Pereyra LH; Condie RM
    J Thorac Cardiovasc Surg; 1978 Apr; 75(4):536-41. PubMed ID: 347179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of pressimmune in renal transplantation: a four-year study.
    Bewick M; Rudge CJ; Miller BH; Monkhouse PM; Reid KE; Verbi V
    Clin Nephrol; 1985 Apr; 23(4):173-8. PubMed ID: 3891177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualization of immediate posttransplant immunosuppression. The value of antilymphocyte globulin in patients with delayed graft function.
    Matas AJ; Tellis VA; Quinn TA; Glicklich D; Soberman R; Veith FJ
    Transplantation; 1988 Feb; 45(2):406-9. PubMed ID: 3278434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response to horse gamma-globulin in recipients of renal allografts: relationship with transplant crises and transplant survival.
    Vincent C; Revillard JP
    Transplantation; 1977 Aug; 24(2):141-7. PubMed ID: 70872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with antilymphocyte globulin in 144 renal transplant recipients.
    Lundgren G; Collste L; Groth CG; Krzymansky M; Magnusson G; Quadracci L; Ringdén O; Svehag SE
    Postgrad Med J; 1976; 52(5 Suppl):67-71. PubMed ID: 792849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.